Evonik
Wednesday, June 28, 2023
4:00 p.m. CEST / 10:00 a.m. EDT

Next generation cystine peptides: Increasing solubility and maximizing cell culture performance with cQrex® KC (Slot 2)

Back to overview

Overview

Evonik Health Care plays a crucial role in improving health outcomes by supporting customers in the pharmaceutical, nutraceutical and medical device industries along the entire product cycle. Although essential, this business can produce a significant amount of waste, which can be detrimental to the environment and human health. Yet, by adopting sustainability as a guiding business principle there are numerous benefits: improved resource and operational efficiency, reduced waste and emissions, improved worker health and safety, and a robust reputation to name a few.

In this webinar, our speaker introduces the concept of sustainability and what it means for Evonik’s Health Care business. She talks about how initiatives are being put in place, their impact, and our ambitions for the future. This webinar is aimed at our customers, potential customers, partners, and any other stakeholders interested in an overview of our sustainability initiatives at Evonik Health Care.

Key learnings for participants:
  • Short introduction to some global sustainability initiatives such as the Paris Climate Agreement, the UN Sustainability Goals and the Science Based Targets initiative
  • How Evonik is addressing some of the challenges related to sustainability
  • Specific goals and measures related to sustainability for the Health Care business at Evonik

Experts featuring this session

Cléa Michel
Product Manager Cell Culture Ingredients
Evonik Health Care

Vita
Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care.

She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance.

Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France.

She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann
Project Manager Cell Culture Ingredients
Evonik Health Care

Vita
Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line.

He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex®® peptides).

Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development.

Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics at EuGENex Biotechnologies GmbH. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Related webinars in this series

This webinar will be repeated on the same day. If you're located in Europe, Middle East, Africa or Asia we recommend our first live session.

Register now

Details

Webinar language
English

Venue

Online

Questions?

Julia Born
Market Communications Health Care
+49 6151 18 4984 E-Mail
Register now
Evonik Health Care
Company Information
Legal Notice
Privacy Policy